MGMT and glioblastoma: Another possible direction to further study PAC-1 in MGMT promoter unmethylated GBM would be to evaluate activity and safety of PAC-1 and radiation (based on previously reported activity of this combined treatment modality in canine patients8), or together with TMZ in MGMT promoter methylated GBM.